Intravenous adenosine and dyspnea in humans

Journal of Applied Physiology
Nausherwan K BurkiLu-Yuan Lee

Abstract

Intravenous adenosine for the treatment of supraventricular tachycardia is reported to cause bronchospasm and dyspnea and to increase ventilation in humans, but these effects have not been systematically studied. We therefore compared the effects of 10 mg of intravenous adenosine with placebo in 21 normal subjects under normoxic conditions and evaluated the temporal sequence of the effects of adenosine on ventilation, dyspnea, and heart rate. The study was repeated in 11 of these subjects during hyperoxia. In all subjects, adenosine resulted in the development of dyspnea, assessed by handgrip dynamometry, without any significant change (P > 0.1) in lung resistance as measured by the interrupter technique. There were significant increases (P < 0.05) in ventilation and heart rate in response to adenosine. The dyspneic response occurred slightly before the ventilatory or heart rate responses in every subject, but the timing of the dyspneic, ventilatory, and heart rate responses was not significantly different when the group data were analyzed (18.9 +/- 5.8, 20.3 +/- 5.5, and 19.7 +/- 4.5 s, respectively). During hyperoxia, adenosine resulted in similar effects, with no significant differences in the magnitude of the ventilatory re...Continue Reading

References

May 1, 1979·The Journal of Clinical Investigation·R K AlbertJ Butler
Jun 1, 1992·The American Review of Respiratory Disease·O TaguchiT Takishima
Jun 1, 1992·The American Journal of Medicine·A C RankinB A McGovern
Dec 1, 1991·Journal of Applied Physiology·O TaguchiT Takishima
May 18, 1990·Neuroscience Letters·M RunoldN R Prabhakar
Sep 1, 1989·Journal of Applied Physiology·G LiistroC Veriter
Oct 1, 1987·Anesthesiology·D L RoerigJ P Kampine
Sep 1, 1987·British Journal of Clinical Pharmacology·R W FullerP J Barnes
Nov 1, 1986·Journal of Applied Physiology·D L MaxwellJ M Hughes
Nov 1, 1985·Journal of Applied Physiology·F L EldridgeJ P Kiley
Nov 1, 1985·Journal of Applied Physiology·C B BurnsR H Ingram
Feb 1, 1974·Journal of Applied Physiology·A C JacksonJ R Norman
Aug 1, 1969·The Journal of Physiology·A S Paintal
Feb 1, 1983·British Journal of Clinical Pharmacology·M J CushleyS T Holgate
Sep 1, 1984·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·S R Muza, F W Zechman
Jan 1, 1984·Reviews of Physiology, Biochemistry and Pharmacology·J C Coleridge, H M Coleridge
Jul 1, 1982·Respiration Physiology·F B Sant'Ambrogio, G Sant'Ambrogio
Dec 7, 1995·The New England Journal of Medicine·H L Manning, R M Schwartzstein
Jan 1, 1995·The Journal of Physiology·H RajA S Paintal
Jun 30, 2001·American Heart Journal·K K Balan, M Critchley

❮ Previous
Next ❯

Citations

Oct 6, 2010·Age·Teresa Castro MonteiroEmília Carreira Monteiro
Feb 5, 2008·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Eva FrickeOliver Lindner
Nov 20, 2012·Chemical Senses·Daniel N Willis, John B Morris
Apr 1, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Christopher R DesesaJohn B Morris
Dec 2, 2006·Respiratory Research·Nausherwan K BurkiLu-Yuan Lee
Nov 4, 2005·Proceedings of the American Thoracic Society·Bradley J Undem, Marian Kollarik
Jun 29, 2012·Hämostaseologie·E Giannitsis, H A Katus
Aug 29, 2012·Expert Opinion on Drug Metabolism & Toxicology·Sonya BurgessCraig P Juergens
Sep 7, 2012·Expert Opinion on Drug Safety·Christopher H May, A Michael Lincoff
Dec 28, 2012·Expert Opinion on Pharmacotherapy·Wah Wah Htun, Steven R Steinhubl
Jan 13, 2009·Respiratory Physiology & Neurobiology·Bradley J Undem, Christina Nassenstein
Mar 2, 2010·Pulmonary Pharmacology & Therapeutics·Nausherwan K Burki, Lu-Yuan Lee
Nov 6, 2010·Chest·Nausherwan K Burki, Lu-Yuan Lee
Dec 1, 2017·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yang-Ling ChouBrendan J Canning
Jan 25, 2006·British Journal of Pharmacology·Sandra KeirClive Page
Jun 24, 2006·The Journal of Physiology·Benjamas ChuaychooBradley J Undem
Jul 15, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ryan P VaughanJohn B Morris
Sep 5, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yang-Ling ChouBrendan J Canning
Feb 1, 2009·Expert Review of Respiratory Medicine·Sara BoothShakeeb H Moosavi
Mar 25, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Daniel CaldeiraJoaquim J Ferreira
Aug 14, 2012·Pharmacological Reviews·Geoffrey BurnstockJean-Pierre Timmermans
Jul 23, 2013·Journal of Applied Physiology·Capucine Morélot-PanziniThomas Similowski
Oct 16, 2018·Cardiovascular & Hematological Disorders Drug Targets·Trevor SimardBenjamin Hibbert
May 29, 2013·Pharmacotherapy·Yuly G BelchikovElissa M Dipasquale
Dec 28, 2017·Expert Opinion on Pharmacotherapy·Dorota DanielakFranciszek Główka
Dec 7, 2016·Journal of Pharmacy Practice·Sarah A MinnerAtman P Shah
Jan 14, 2016·British Journal of Pharmacology·Sven Nylander, Rainer Schulz
Jun 16, 2012·Expert Review of Clinical Pharmacology·Yanushi Dullewe WijeyeratneStan Heptinstall
Nov 23, 2010·Pacing and Clinical Electrophysiology : PACE·Charalampos KriatselisMichael Orlov
Jan 15, 2014·Journal of Cardiovascular Pharmacology and Therapeutics·Duncan ArmstrongJ J J van Giezen
Jun 24, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·J J J van GiezenJan-Arne Björkman
Jul 21, 2020·Arrhythmia & Electrophysiology Review·Gareth Dk Matthews, Andrew A Grace
Oct 27, 2020·Clinical Medicine Insights. Case Reports·Alicja KrakowiakAgnieszka Cudnoch-Jędrzejewska
Feb 23, 2010·Otolaryngologic Clinics of North America·Brendan J Canning
Jul 21, 2021·Pharmacological Reports : PR·Mohammed Ahmed AkkaifBaharudin Ibrahim
Nov 2, 2021·Frontiers in Physiology·Eduardo Salazar-MartínezAlejandro Lucia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.